Literature DB >> 6207983

Results of long-term propranolol treatment in myocardial infarction survivors with advanced grades of ventricular extrasystoles.

N A Mazur, I V Kulginskaya, L A Ivanova, T P Ostrovskaya, T M Smirnova, E A Svet, E A Dokuchaeva, V A Vygodin.   

Abstract

204 patients with established ischaemic heart disease, aged up to 62 years, were divided at random into two groups according to the matched pairs principle with respect to factors influencing long-term prognosis. Before randomization, the patients' ECG was monitored for 24 hrs, a treadmill exercise test and roentgencardiography were performed. The follow-up period was about 1.5 years. In the experimental group of 101 patients who were given propranolol in individualized doses (40-320 mg/day), which ensured a decrease in heart rate by 15-20%, sudden coronary death was significantly less frequent (p less than 0.01) than in the control group. The occurrence of repeated non-fatal myocardial infarction did not in the two groups significantly differ. A decrease in the occurrence of ventricular extrasystoles in the propranolol treated group was found only at the exercise test.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207983

Source DB:  PubMed          Journal:  Cor Vasa        ISSN: 0010-8650


  1 in total

Review 1.  Beta-blockers in patients without heart failure after myocardial infarction.

Authors:  Sanam Safi; Naqash J Sethi; Steven Kwasi Korang; Emil Eik Nielsen; Joshua Feinberg; Christian Gluud; Janus C Jakobsen
Journal:  Cochrane Database Syst Rev       Date:  2021-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.